Literature DB >> 26170095

Modelling the molecular mechanism of protein-protein interactions and their inhibition: CypD-p53 case study.

S M Fayaz1, G K Rajanikant2.   

Abstract

Cyclophilin D (CypD) is an important regulatory protein involved in mitochondrial membrane permeability transition and cell death. Further, the mitochondrial CypD-p53 axis is an important contributor to necroptosis, a form of programmed necrosis, involved in various cardiovascular and neurological disorders. The CypD ligand, Cyclosporin A (CsA), was identified as an inhibitor of this interaction. In this study, using computational methods, we have attempted to model the CypD-p53 interaction in order to delineate their mode of binding and also to disclose the molecular mechanism, by means of which CsA interferes with this interaction. It was observed that p53 binds at the CsA-binding site of CypD. The knowledge obtained from this modelling was employed to identify novel CypD inhibitors through structure-based methods. Further, the identified compounds were tested by a similar strategy, adopted during the modelling process. This strategy could be applied to study the mechanism of protein-protein interaction (PPI) inhibition and to identify novel PPI inhibitors.

Entities:  

Keywords:  Cyclophilin D; Cyclosporin A; Necroptosis; Neurological disorders; Protein–protein interactions; p53

Mesh:

Substances:

Year:  2015        PMID: 26170095     DOI: 10.1007/s11030-015-9612-4

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  67 in total

1.  A biomolecular force field based on the free enthalpy of hydration and solvation: the GROMOS force-field parameter sets 53A5 and 53A6.

Authors:  Chris Oostenbrink; Alessandra Villa; Alan E Mark; Wilfred F van Gunsteren
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

2.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.

Authors:  Richard A Friesner; Jay L Banks; Robert B Murphy; Thomas A Halgren; Jasna J Klicic; Daniel T Mainz; Matthew P Repasky; Eric H Knoll; Mee Shelley; Jason K Perry; David E Shaw; Perry Francis; Peter S Shenkin
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

3.  ZINC--a free database of commercially available compounds for virtual screening.

Authors:  John J Irwin; Brian K Shoichet
Journal:  J Chem Inf Model       Date:  2005 Jan-Feb       Impact factor: 4.956

4.  A discussion of measures of enrichment in virtual screening: comparing the information content of descriptors with increasing levels of sophistication.

Authors:  Andreas Bender; Robert C Glen
Journal:  J Chem Inf Model       Date:  2005 Sep-Oct       Impact factor: 4.956

5.  The prolyl cis/trans isomerase cyclophilin 18 interacts with the tumor suppressor p53 and modifies its functions in cell cycle regulation and apoptosis.

Authors:  N Baum; C Schiene-Fischer; M Frost; M Schumann; K Sabapathy; O Ohlenschläger; F Grosse; B Schlott
Journal:  Oncogene       Date:  2009-08-31       Impact factor: 9.867

6.  T lymphocyte activation signals for interleukin-2 production involve activation of MKK6-p38 and MKK7-SAPK/JNK signaling pathways sensitive to cyclosporin A.

Authors:  S Matsuda; T Moriguchi; S Koyasu; E Nishida
Journal:  J Biol Chem       Date:  1998-05-15       Impact factor: 5.157

7.  Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death.

Authors:  Takashi Nakagawa; Shigeomi Shimizu; Tetsuya Watanabe; Osamu Yamaguchi; Kinya Otsu; Hirotaka Yamagata; Hidenori Inohara; Takeshi Kubo; Yoshihide Tsujimoto
Journal:  Nature       Date:  2005-03-31       Impact factor: 49.962

8.  Study of drug resistance of chicken influenza A virus (H5N1) from homology-modeled 3D structures of neuraminidases.

Authors:  Shu-Qing Wang; Qi-Shi Du; Kou-Chen Chou
Journal:  Biochem Biophys Res Commun       Date:  2007-01-19       Impact factor: 3.575

9.  Molecular dynamics studies on the interactions of PTP1B with inhibitors: from the first phosphate-binding site to the second one.

Authors:  Jing-Fang Wang; Ke Gong; Dong-Qing Wei; Yi-Xue Li; Kuo-Chen Chou
Journal:  Protein Eng Des Sel       Date:  2009-04-19       Impact factor: 1.650

10.  Novel inhibitor design for hemagglutinin against H1N1 influenza virus by core hopping method.

Authors:  Xiao-Bo Li; Shu-Qing Wang; Wei-Ren Xu; Run-Ling Wang; Kuo-Chen Chou
Journal:  PLoS One       Date:  2011-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.